[ET Net News Agency, 25 March 2024] SKB BIO-B (06990) rose 7.4% to HK$176.
It hits an intra-day high of HK$176, hitting a historical high, and an intra-day low of
HK$157.2. The total shares traded was 91,000, with a value of HK$15.29m. The active
buy/sell ratio is 56:44, with net buying turnover of HK$1.72m. CHINA INNOVATION MARKET SER
accounts for greatest net responsive buying turnover of HK$904,769, with volume weighted
average price of HK$169.223. FUTU SEC INT'L accounts for greatest net responsive selling
turnover of HK$1.67m, with volume weighted average price of HK$169.409. The stock has
risen a combined 19.6% over the past 5 consecutive trading days.
Basic Information
=================
-----------------------------------
Nominal 176.000 % Chg +7.45%
High 176.000 Low 157.200
Shares Tr 91,000 Turnover 15.29m
10-D SMA 151.430 %H.V 89.032
20-D SMA 132.655 VWAP 167.991
50-D SMA 107.936 RSI14 81.929
-----------------------------------
Status: Hitting a historical high, active buy/sell ratio is 56:44, with net buying
turnover of HK$1.72m, rising a combined 19.6% over the past 5 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
SKB BIO-B (06990) 176.00 +7.45
HUTCHMED (00013) 27.55 +5.35
GENSCRIPT BIO (01548) 15.06 +2.87
INNOVENT BIO (01801) 37.95 +5.42
EVEREST MED-B (01952) 23.30 -4.51
SIRNAOMICS-B (02257) 9.37 +17.42
WUXI XDC (02268) 18.90 +5.59
WUXI BIO (02269) 14.08 +7.98
TIGERMED (03347) 30.40 +2.53
AKESO (09926) 47.80 +3.69
---------------------------------------------
(ed)